The rest of the story: The microbiome and gastrointestinal infections

Current Opinion in Microbiology

Volumn 23, Issue , 2015, Pages 121-125

  Leslie, Jhansi L ^a   Young, Vincent B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN;

BACTERIAL INFECTION; BACTERIAL METABOLISM; BACTEROIDETES; CITROBACTER RODENTIUM; FIRMICUTES; GASTROINTESTINAL INFECTION; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; IMMUNOREGULATION; INTESTINE FLORA; MICROBIOME; NONHUMAN; NUTRIENT; REVIEW; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; IMMUNOLOGY; MICROBIOLOGY; MICROFLORA; ORGANISMAL INTERACTION;

GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; MICROBIAL INTERACTIONS; MICROBIOTA;

EID: 84913557714     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2014.11.010     Document Type: Review

References (45)

1. Ley R.E., Lozupone C.A., Hamady M., Knight R., Gordon J.I. Worlds within worlds: evolution of the vertebrate gut microbiota. Nat Rev Microbiol 2008, 6:776-788.
2. Chung H., Pamp S.J., Hill J.A., Surana N.K., Edelman S.M., Troy E.B., Reading N.C., Villablanca E.J., Wang S., Mora J.R., et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 2012, 149:1578-1593.
3. Semova I., Carten J.D., Stombaugh J., Mackey L.C., Knight R., Farber S.A., Rawls J.F. Microbiota regulate intestinal absorption and metabolism of fatty acids in the zebrafish. Cell Host Microbe 2012, 12:277-288.
4. Aagaard K., Ma J., Antony K.M., Ganu R., Petrosino J., Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med 2014, 6:237ra265.
5. Morris A., Beck J.M., Schloss P.D., Campbell T.B., Crothers K., Curtis J.L., Flores S.C., Fontenot A.P., Ghedin E., Huang L., et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am J Respir Crit Care Med 2013, 187:1067-1075.
6. The Human Microbiome Project Consortium: structure, function and diversity of the healthy human microbiome. Nature 2012, 486:207-214.
7. Vujkovic-Cvijin I., Dunham R.M., Iwai S., Maher M.C., Albright R.G., Broadhurst M.J., Hernandez R.D., Lederman M.M., Huang Y., Somsouk M., et al. Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci Transl Med 2013, 5:193ra191.
8. Erickson A.R., Cantarel B.L., Lamendella R., Darzi Y., Mongodin E.F., Pan C., Shah M., Halfvarson J., Tysk C., Henrissat B., et al. Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn's disease. PLoS ONE 2012, 7:e49138.
9. Cho I., Yamanishi S., Cox L., Methe B.A., Zavadil J., Li K., Gao Z., Mahana D., Raju K., Teitler I., et al. Antibiotics in early life alter the murine colonic microbiome and adiposity. Nature 2012, 488:621-626.
10. Cox L.M., Yamanishi S., Sohn J., Alekseyenko A.V., Leung J.M., Cho I., Kim S.G., Li H., Gao Z., Mahana D., et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell 2014, 158:705-721.
11. Theriot C.M., Koenigsknecht M.J., Carlson P.E., Hatton G.E., Nelson A.M., Li B., Huffnagle G.B., J Z.L., Young V.B. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun 2014, 5:3114.
12. Ridlon J.M., Kang D.J., Hylemon P.B., Bajaj J.S. Bile acids and the gut microbiome. Curr Opin Gastroenterol 2014, 30:332-338.
13. Francis M.B., Allen C.A., Shrestha R., Sorg J.A. Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection. PLoS Pathog 2013, 9:e1003356.
14. Sorg J.A., Sonenshein A.L. Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid. J Bacteriol 2010, 192:4983-4990.
15. Buffie C.G., Bucci V., Stein R.R., McKenney P.T., Ling L., Gobourne A., No D., Liu H., Kinnebrew M., Viale A., et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2014, (advance online publication).
16. Arpaia N., Campbell C., Fan X., Dikiy S., van der Veeken J., deRoos P., Liu H., Cross J.R., Pfeffer K., Coffer P.J., et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013, 504:451-455.
17. Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A., Bohlooly Y.M., Glickman J.N., Garrett W.S. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013, 341:569-573.
18. Johanns T.M., Ertelt J.M., Rowe J.H., Way S.S. Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog 2010, 6:e1001043.
19. Atarashi K., Tanoue T., Oshima K., Suda W., Nagano Y., Nishikawa H., Fukuda S., Saito T., Narushima S., Hase K., et al. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013, 500:232-236.
20. Faith J.J., Ahern P.P., Ridaura V.K., Cheng J., Gordon J.I. Identifying gut microbe-host phenotype relationships using combinatorial communities in gnotobiotic mice. Sci Transl Med 2014, 6:220ra211.
21. Khosravi A., Yanez A., Price J.G., Chow A., Merad M., Goodridge H.S., Mazmanian S.K. Gut microbiota promote hematopoiesis to control bacterial infection. Cell Host Microbe 2014, 15:374-381.
22. Uchiyama R., Chassaing B., Zhang B., Gewirtz A.T. Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity. J Infect Dis 2014, 210:171-182.
23. Abt M.C., Osborne L.C., Monticelli L.A., Doering T.A., Alenghat T., Sonnenberg G.F., Paley M.A., Antenus M., Williams K.L., Erikson J., et al. Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity 2012, 37:158-170.
24. Stearns J.C., Lynch M.D., Senadheera D.B., Tenenbaum H.C., Goldberg M.B., Cvitkovitch D.G., Croitoru K., Moreno-Hagelsieb G., Neufeld J.D. Bacterial biogeography of the human digestive tract. Sci Rep 2011, 1:170.
25. Marteyn B., West N.P., Browning D.F., Cole J.A., Shaw J.G., Palm F., Mounier J., Prevost M.C., Sansonetti P., Tang C.M. Modulation of Shigella virulence in response to available oxygen in vivo. Nature 2010, 465:355-358.
26. Albenberg L., Esipova T.V., Judge C.P., Bittinger K., Chen J., Laughlin A., Grunberg S., Baldassano R.N., Lewis J.D., Li H., et al. Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota. Gastroenterology 2014, 147. 1055-1063.e1058.
27. Rivera-Chavez F., Winter S.E., Lopez C.A., Xavier M.N., Winter M.G., Nuccio S.P., Russell J.M., Laughlin R.C., Lawhon S.D., Sterzenbach T., et al. Salmonella uses energy taxis to benefit from intestinal inflammation. PLoS Pathog 2013, 9:e1003267.
28. Winter S.E., Winter M.G., Xavier M.N., Thiennimitr P., Poon V., Keestra A.M., Laughlin R.C., Gomez G., Wu J., Lawhon S.D., et al. Host-derived nitrate boosts growth of E. coli in the inflamed gut. Science 2013, 339:708-711.
29. Spees A.M., Wangdi T., Lopez C.A., Kingsbury D.D., Xavier M.N., Winter S.E., Tsolis R.M., Baumler A.J. Streptomycin-induced inflammation enhances Escherichia coli gut colonization through nitrate respiration. MBio 2013, 4.
30. Majeed H., Lampert A., Ghazaryan L., Gillor O. The weak shall inherit: bacteriocin-mediated interactions in bacterial populations. PLoS ONE 2013, 8:e63837.
31. Wang B.Y., Kuramitsu H.K. Interactions between oral bacteria: inhibition of Streptococcus mutans bacteriocin production by Streptococcus gordonii. Appl Environ Microbiol 2005, 71:354-362.
32. Cotter P.D., Ross R.P., Hill C. Bacteriocins - a viable alternative to antibiotics?. Nat Rev Microbiol 2013, 11:95-105.
33. Birri D.J., Brede D.A., Tessema G.T., Nes I.F. Bacteriocin production, antibiotic susceptibility and prevalence of haemolytic and gelatinase activity in faecal lactic acid bacteria isolated from healthy Ethiopian infants. Microb Ecol 2013, 65:504-516.
34. Lakshminarayanan B., Guinane C.M., O'Connor P.M., Coakley M., Hill C., Stanton C., O'Toole P.W., Ross R.P. Isolation and characterization of bacteriocin-producing bacteria from the intestinal microbiota of elderly Irish subjects. J Appl Microbiol 2013, 114:886-898.
35. Rea M.C., Alemayehu D., Casey P.G., O'Connor P.M., Lawlor P.G., Walsh M., Shanahan F., Kiely B., Ross R.P., Hill C. Bioavailability of the anti-clostridial bacteriocin thuricin CD in gastrointestinal tract. Microbiology 2014, 160:439-445.
36. Crost E.H., Pujol A., Ladire M., Dabard J., Raibaud P., Carlier J.P., Fons M. Production of an antibacterial substance in the digestive tract involved in colonization-resistance against Clostridium perfringens. Anaerobe 2010, 16:597-603.
37. Deriu E., Liu J.Z., Pezeshki M., Edwards R.A., Ochoa R.J., Contreras H., Libby S.J., Fang F.C., Raffatellu M. Probiotic bacteria reduce Salmonella typhimurium intestinal colonization by competing for iron. Cell Host Microbe 2013, 14:26-37.
38. Maier L., Vyas R., Cordova C.D., Lindsay H., Schmidt T.S., Brugiroux S., Periaswamy B., Bauer R., Sturm A., Schreiber F., et al. Microbiota-derived hydrogen fuels Salmonella typhimurium invasion of the gut ecosystem. Cell Host Microbe 2013, 14:641-651.
39. Ng K.M., Ferreyra J.A., Higginbottom S.K., Lynch J.B., Kashyap P.C., Gopinath S., Naidu N., Choudhury B., Weimer B.C., Monack D.M., et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013, 502:96-99.
40. Lawley T.D., Clare S., Walker A.W., Stares M.D., Connor T.R., Raisen C., Goulding D., Rad R., Schreiber F., Brandt C., et al. Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 2012, 8:e1002995.
41. van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E.G., de Vos W.M., Visser C.E., Kuijper E.J., Bartelsman J.F., Tijssen J.G., et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013, 368:407-415.
42. Ubeda C., Bucci V., Caballero S., Djukovic A., Toussaint N.C., Equinda M., Lipuma L., Ling L., Gobourne A., No D., et al. Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization. Infect Immun 2013, 81:965-973.
43. Kinnebrew M.A., Ubeda C., Zenewicz L.A., Smith N., Flavell R.A., Pamer E.G. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection. J Infect Dis 2010, 201:534-543.
44. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., Abbas A.R., Modrusan Z., Ghilardi N., de Sauvage F.J., et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 2008, 14:282-289.
45. Behnsen J., Jellbauer S., Wong C.P., Edwards R.A., George M.D., Ouyang W., Raffatellu M. The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. Immunity 2014, 40:262-273.